Clinical trials
Phase 1 Basal Cell Carcinoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2004 | 2 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Recruiting | 4 |
| Terminated | 3 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Case Comprehensive Cancer Center | 3 |
| Novartis Pharmaceuticals | 2 |
| Roswell Park Cancer Institute | 2 |
| Bristol-Myers Squibb | 1 |
| Center for Biomedical Research, Inc. | 1 |
| CivaTech Oncology | 1 |
| Eastern Virginia Medical School | 1 |
| Genzada Pharmaceuticals USA, Inc. | 1 |
| Incyte Corporation | 1 |
| Jean Yuh Tang | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Basal Cell Carcinoma | 33 |
| Skin Neoplasms | 9 |
| Cutaneous Squamous Cell Carcinoma | 8 |
| Melanoma | 6 |
| Breast Neoplasms | 4 |
| Carcinoma, Merkel Cell | 4 |
| Lymphoma | 4 |
| Sarcoma | 4 |
| Squamous Cell Carcinoma of Head and Neck | 4 |
| Carcinoma, Squamous Cell | 3 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.